Medigen Selected for WHO Trial

Reporter/Provider - Sandy Chi, Asnaya Chou

class="meta mb-0">Publish Date - 2021-10-27T18:28:23Z0 views

Taiwan’s homegrown COVID vaccine, Medigen, is set to enter clinical trials under a WHO platform. The government hopes this could pave the way for greater international approval of the vaccine.

We value your privacy.

We use cookies to analyze the traffic of TaiwanPlus to improve our service. Click here to find out more about TaiwanPlus's privacy policy.

Learn more Got it

Like what you see?

Download TaiwanPlus App now!